 And it's also looking at workarounds to minimize interruptions. Shares of both FedEx and UPS are down. People in China will now be able to get their hands on the latest weight loss drugs. Eli Lilly's Monjaro has landed Chinese regulatory approval for weight loss less than a month after a similar therapy from Novo Nordisk. The move fuels competition in a nation that's among the world's most severely hit by obesity. Lilly shares are gaining 2%.